Most Recent
A judge has allowed a unit of recruitment firm Tandem to file cross-claims against individual group members in an underpayment class action, in a rare move that may spark important changes in representative proceedings.
A group of women harmed by pelvic mesh devices produced by Johnson & Johnson have accused it of persisting with a "wreckage" of a case in which one of its own doctors admitted the pharmaceutical company knew of the risks posed by the implants at they time they were sold worldwide.
The Morrison government faces a fifth class action alleging the use of toxic firefighting foam at a Defence Force base on the South Coast of New South Wales contaminated Indigenous land.
The judge who found J&J's pelvic mesh implants defective in a high stakes class action ruling mde a "pervasive error" in disregarding the knowledge and views of the applicants' doctors, an appeals court has heard.
Law firm Clayton Utz and litigation funder Investor Claim Partners have joined forces to bring a class action against insurers who have denied business interruption claims by business impacted by the COVID-19 pandemic.
At least five law firms are investigating lawsuits, including class action proceedings, in the wake of a landmark test case on COVID-19 exclusions for business interruption cover.
Payouts in class actions in 2020 largely kept pace with the previous year despite the financial strain of the COVID-19 pandemic, with companies and other defendants paying more than $696 million to settle class actions last year.
Properties near seven air force bases where allegedly toxic firefighting foam was used experienced a drop in land value because of the "stigma" of contamination, according to an expert report accepted by the Federal Court in a class action seeking compensation from the Federal government.
Two law firms that have filed competing class action against AMP over allegedly excessive insurance premiums have changed tack and agreed to consolidate the proceedings.
A unit of Johnson & Johnson has been ordered to pay around $40 million in legal costs to the lead applicants in a class action over pelvic mesh implants after a judge dismissed the company's bid to stay the costs until after a high profile appeal is heard next year.